CAN-FITE BIOPHARMA LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 USD | -3.35% |
|
-4.04% | -8.18% |
| 12/05 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
| 09/05 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Chart calendar Can-Fite BioPharma Ltd.
b.YPm44nFZD5UFpgqQ5Dv71xpXGPfCjun0vP5j_o0xyw4.EMCBk1wtNvhXzXDop1zCtlxvS7i4v9-sxqgnmt5TiUwavYCSOjxn_kfkPg~011965984dd3f1b12d87cd79e4c6e721
Upcoming events on Can-Fite BioPharma Ltd.
Past events on Can-Fite BioPharma Ltd.
| 30/05/2024 | Q1 2024 Earnings Release (Projected) |
| 02/05/2024 03:30 am | Planet MicroCap Showcase |
| 10/04/2024 02:00 am | LD Micro Invitational Conference |
| 28/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 18/03/2024 | BioEurope Spring Conference |
| 25/01/2024 07:30 pm | Sequire Investor Summit |
| 30/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 11/10/2023 | Bio Japan Conference |
| 27/09/2023 | AACR Conference |
| 11/09/2023 09:30 am | H.C. Wainwright Global Investment Conference |
| 07/09/2023 | Emerging Growth Conference |
| 31/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 11/08/2023 | Emerging Growth Conference |
| 04/08/2023 | American Society of Clinical Oncology Meeting |
| 13/07/2023 08:55 pm | Emerging Growth Conference |
| 01/06/2023 04:30 pm | Q1 2023 Earnings Release |
| 14/05/2023 | Bio Equity Europe Conference |
| 30/03/2023 04:45 pm | Q4 2022 Earnings Release |
| 20/03/2023 | BIO Europe Spring Conference |
| 10/06/2021 | BIO International Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,03 1,80 12.89% | 0,76 1,10 -30.64% | 0,85 0,90 -5.15% | 0,81 1,41 -42.7% | 0,74 0,80 -7.13% | 0,90 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -12,0 -10,8 -11.14% | -14,1 -12,9 -9.6% | -12,8 -12,4 -3.49% | -10,1 -13,9 27.17% | -8,20 -8,30 1.27% | -8,18 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,59 -11,4 15.9% | -14,4 -13,2 -9.42% | -12,6 -12,2 -2.99% | -10,2 -9,20 -10.58% | -7,63 -7,90 3.37% | -9,10 |
|
Net income Million USD | Released Forecast Spread | -9,59 -11,4 15.9% | -14,4 -13,9 -3.91% | -12,6 -12,1 -4.42% | -10,2 -14,2 28.14% | -7,63 -7,90 3.37% | -7,88 |
|
EPS ILS | Released Forecast Spread | -0,39 -0,48 17.7% | -0,13 -0,13 -0.17% | -0,10 -0,06 -55.9% | -0,04 -0,05 30.56% | -0,04 -0,04 0.76% | 0,00 |
| Announcement Date | 27/03/20 | 25/03/21 | 24/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,20 0,27 -23.5% | 0,21 0,20 2.5% | 0,20 0,25 -18.4% | 0,20 0,30 -32% | 0,20 0,50 -60.6% | 0,20 0,00 - | 0,20 0,20 -2% | 0,20 0,20 -2% | 0,16 0,20 -22.5% | 0,30 | 0,30 | 0,30 | 0,30 |
|
EBIT Million USD | Released Forecast Spread | -4,03 -3,60 -11.89% | -2,37 -3,05 22.3% | -2,07 -2,55 18.82% | -2,57 -2,98 13.51% | -3,08 -3,40 9.32% | -1,78 -2,90 38.48% | -1,87 -1,80 -3.61% | -1,83 -1,90 3.47% | -1,90 | -2,10 | -2,40 | -2,80 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,12 -3,75 -9.81% | -2,43 -3,02 19.27% | -2,19 -2,30 4.74% | -2,53 -1,90 -33.11% | -3,02 -2,00 -50.95% | -1,67 -2,70 38.15% | -1,76 -1,70 -3.65% | -1,65 -1,90 13.05% | -1,90 | -2,10 | -2,40 | -2,70 | |
|
Net income Million USD | Released Forecast Spread | -4,12 -3,58 -14.92% | -2,43 -3,02 19.27% | -2,19 -2,50 12.36% | -2,53 -2,93 13.54% | -3,02 -3,45 12.49% | -1,67 -2,80 40.36% | -1,76 -1,70 -3.65% | -1,65 -1,90 13.05% | -1,90 | -2,10 | -2,40 | -2,70 | |
|
EPS ILS | Released Forecast Spread | -0,03 -0,03 -3.94% | 0,00 0,00 - | 0,00 0,00 - | -0,03 0,00 - | 0,00 -0,02 - | 0,00 0,00 - | 0,00 0,00 - | -0,04 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
| Announcement Date | 24/03/22 | 26/05/22 | 25/08/22 | 25/11/22 | 30/03/23 | 01/06/23 | 31/08/23 | 30/11/23 | 28/03/24 | - | - | - | - |
| 11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
| 26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Can-Fite BioPharma Ltd.
| 23/05/2024 03:13 pm | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 13/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CANF Stock
- CANF Stock
- Calendar Can-Fite BioPharma Ltd.
